In this paper we deal with the capital structure problem in the pharmaceutical industry that has recently changed its business model because of the biotechnology advent. We propose a set of hypotheses that explains the drivers of capital structure decision in this industry and then we test their validity over a sample of 50 biopharmaceutical firms. The obtained results show that pecking order theory is suitable to explain intra industry differences in capital structure while growth opportunities are the most explicative variable.
Zambuto, F., Billitteri, C., Lo Nigro, G. (2011). Capital Structure Decisions in the Biopharmaceutical Industry. In 2nd International Conference on Industrial Engineering and Operations Management (IEOM)_Kuala Lumpur, Malaysia, January 22 – 24, 2011.
Capital Structure Decisions in the Biopharmaceutical Industry
ZAMBUTO, Fabio;BILLITTERI, Carolina;LO NIGRO, Giovanna
2011-01-01
Abstract
In this paper we deal with the capital structure problem in the pharmaceutical industry that has recently changed its business model because of the biotechnology advent. We propose a set of hypotheses that explains the drivers of capital structure decision in this industry and then we test their validity over a sample of 50 biopharmaceutical firms. The obtained results show that pecking order theory is suitable to explain intra industry differences in capital structure while growth opportunities are the most explicative variable.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Determinants of Capital Structure in the Biopharmaceutical Industry.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
83.38 kB
Formato
Adobe PDF
|
83.38 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
